Improving glucose management in older adults with type 1 diabetes through data sharing
NIDDK Share Plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with T1D and Their Care Partners
This study tests a new way for older adults with type 1 diabetes and their care partners to share glucose data using an app to see if it helps them manage their blood sugar better and feel less stressed about diabetes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Trial ID | NCT05937321 on ClinicalTrials.gov |
What this trial studies
This study tests the Share plus intervention, which aims to enhance data sharing between older adults with type 1 diabetes and their care partners using continuous glucose monitoring (CGM) technology. Participants will receive training on how to use a data-sharing app, communicate effectively, and create a data-sharing action plan. The goal is to improve time-in-range for glucose levels and reduce diabetes-related distress for both the individuals with diabetes and their care partners over a 12- and 24-week period.
Who should consider this trial
Good fit: Ideal candidates include older adults aged 60 and above with a diagnosis of type 1 diabetes who are currently using continuous glucose monitoring.
Not a fit: Patients with a life expectancy of less than one year or significant cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could lead to better glucose management and reduced diabetes distress for older adults with type 1 diabetes and their care partners.
How similar studies have performed: Other studies have shown promise in using technology and data sharing to improve diabetes management, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria for PWD: * 60 + years of age * Type 1 Diabetes Diagnosis * HbA1c no greater than 11.0% * Currently using continuous glucose monitoring * Able to manage diabetes with respect to insulin administration and glucose monitoring (which may include assistance from a care partner Inclusion Criteria for CP: * ≥18 years of age * Participant understands the study protocol and agrees to comply with it Exclusion Criteria for PWD: * Life expectancy estimated at \< 1 year * Extreme visual or hearing impairment that would hinder the ability to use CGM * Stage 4 or 5 renal disease or most recent Glomerular filtration rate (GFR) \<30 ml/min/m2 from a local lab within the past six months * The presence of a significant medical or psychiatric condition or use of a medication that in the investigator's judgment may affect the completion of any aspect of the protocol. * Clinical diagnosis of moderate or severe dementia * Inpatient psychiatric treatment in the past six months * Participation in an intervention study in the past six weeks * Montreal Cognitive Assessment Score \< 19 Exclusion criteria for CP: * Cognitive impairment or dementia * Medical condition that will make it inappropriate or unsafe to fulfill the role of a CP
Where this trial is running
Salt Lake City, Utah
- University of Utah College of Nursing — Salt Lake City, Utah, United States (Recruiting)
Study contacts
- Principal investigator: Nancy A Allen, PhD — University of Utah College of Nursing
- Study coordinator: Bruno Gonzales, BA
- Email: Bruno.Rodriguez-Gonzales@utah.edu
- Phone: 8015855958
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.